Pharmaceutical Preparations · DE · CIK 2093101
Develops RNA-based cardiac therapeutics targeting specific gene mutations for cardiomyopathies
Comparable business profile · signals at a glance
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗